Immix Biopharma Newsroom

HC Wainwright & Co. Reiterates Buy on Immix Biopharma, Maintains $7 Price Target

BenzingaJul 26 07:03 ET

Immix Biopharma Analyst Ratings

BenzingaJul 26 06:58 ET

H.C. Wainwright Maintains Immix Biopharma(IMMX.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsJul 26 06:31 ET

Immix Biopharma Analyst Ratings

BenzingaJul 9 06:47 ET

Buy Rating Affirmed for Immix Biopharma Amid Promising NXC-201 Trial Outcomes and Market Potential

TipRanksJul 9 06:19 ET

Buy Rating for Immix Biopharma Backed by Promising N-GENIUS Platform and Strong NXC-201 Sales Potential

TipRanksJul 1 06:18 ET

Immix Biopharma Analyst Ratings

BenzingaJul 1 06:10 ET

Roth MKM Reiterates Buy on Immix Biopharma, Maintains $14 Price Target

BenzingaAug 14, 2023 10:11 ET

Immix Biopharma Analyst Ratings

BenzingaAug 14, 2023 10:10 ET

Roth MKM Keeps Their Buy Rating on Immix Biopharma, Inc. (IMMX)

TipRanksFeb 28, 2023 08:41 ET

Immix Biopharma Analyst Ratings

Benzinga Analyst RatingsFeb 22, 2023 08:28 ET

Roth MKM Initiates Coverage On Immix Biopharma With Buy Rating, Announces Price Target of $14

Benzinga Real-time NewsFeb 22, 2023 08:21 ET